{"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.004","statisticalComment":"Adjusting for stratification factor (Hepatocellular carcinoma versus liver metastases)","statisticalMethod":"Cochran-Mantel-Haenszel"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"18"}],"units":"Participants"}],"description":"• Proportion of patients achieving improvement of liver cancer pain/discomfort by ≥ 2 points in pain \"intensity at worst \" on Brief Pain Inventory (BPI) from baseline to day 30.","groups":[{"description":"Patients receive a radiation therapy with the use of 8 Gy in one fraction to the whole (or near-whole) liver together with the best supportive care.","id":"OG000","title":"Radiotherapy Combined With Best Supportive Care"},{"description":"Patients receive only the best supportive care.","id":"OG001","title":"Best Supportive Care Alone"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All patients who completed both baseline and day 30 assessments","reportingStatus":"POSTED","timeFrame":"30 days","title":"Proportion of Patients Achieving Significant Improvement of Liver Cancer Pain/Discomfort","type":"PRIMARY","unitOfMeasure":"Participants"}